Posts Tagged ‘Medical Development Group’

Help Determine Go to Market Strategy for Life Sciences Startup

Tuesday, May 22nd, 2012

Innovators, entrepreneurs, service providers, and marketing and sales professionals in the medical device/life sciences communities who are interested in learning about emerging companies should consider attending our next Determining Go to Market Strategy for an Early Stage Life Sciences Company, which I will be moderating.

This viable, early stage life sciences company is positioned to transform the clinical research and drug discovery industries with their cutting edge technology that has been validated at Harvard, Tufts, and UMass laboratories. Initial product launch is scheduled for Q1 2013.

The CEO of the subject company will present how this new technology was developed and reveal how deploying a virtual business model will shorten the path to positive cash flow.

Event participants and a panel of marketing and sales professionals will engage in an interactive strategic assessment to make specific recommendations to the leadership of the subject company. Teams will strategize as to how the technology should be positioned in the marketplace, identify the pricing model, and recommend which sales /distribution model would be most effective.

The event will start with a light dinner and interactive networking. Pre-registration is strongly recommended as we expect this event to sell out.

This event is being presented by the Marketing and Sales Special Interest Group of the Medical Development Group Association, and will be held at Rebecca’s Riverside Café, 275 Grove Street, Newton, MA from 5:30-8:00pm next Wednesday, May 30th. More information, pre-registration, and directions to the event can be found here.

Determining Go to Market Strategy Rescheduled to March 21st

Thursday, February 23rd, 2012

It takes an incredible amount of time, energy, resources, timing, and luck to successfully take a medical device product from concept through commercialization. Only 10 to 20% companies are able to complete the cycle of success of generating positive cash flow and/or getting acquired, as the research I completed last year illustrates. You can review the special report here.

On Wednesday, March 21st, I will serve as moderator of an exciting learning event, Determining Go to Market Strategy for an Early Stage Medical Device Company. This is an interactive strategic assessment between event participants and a panel of marketing and sales professionals which will make recommendations to the leadership of the subject company.

The CEO will demonstrate how new technology his company is developing has the potential to significantly accelerate the success rates of patient care in a growing healthcare epidemic. He will disclose how the evidence from the first three clinical trials shows great promise.

Attendees at this event will have the opportunity to actively participate on a team that will develop specific strategic recommendations for the subject company. Teams will strategize as to which product line should be introduced first, identify the appropriate pricing model, and recommend which sales /distribution model would be most effective.

Marketing and sales professionals, service providers to the medical device/life sciences startup community, innovators, entrepreneurs, and professionals interested in emerging companies should consider attending.

This event is being presented by the Marketing and Sales special interest group of the Medical Development Group association, and being held at the Foley Hoag Emerging Enterprise Center from 5:30-8:00pm on March 21st. More information, pre-registration, and directions to the event can be found here.

Please join us, and pass this along to someone you know who might be interested in attending.